Differential diagnosis of gynecologic organ-related diseases in women presenting with ascites

Taiwanese Journal of Obstetrics and Gynecology

Volumn 47, Issue 4, 2008, Pages 384-390

  Cheng, Ming Huei ^a,b   Yen, Ming Shyen ^a   Chao, Kuan Chong ^a   Sheu, Bor Ching ^c   Wang, Peng Hui ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Ascites; Endometriosis; Epithelial ovarian cancer; Ovarian hyperstimulation syndrome; Peritonitis tuberculosis

Indexed keywords

CABERGOLINE; CARBOPLATIN; CISPLATIN; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOROURACIL; FOLINIC ACID; GONADORELIN AGONIST; MATRIX METALLOPROTEINASE INHIBITOR; TUBERCULOSTATIC AGENT; VASCULOTROPIN INHIBITOR;

ASCITES; ASCITES FLUID ANALYSIS; CANCER IMMUNOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COLLOID; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ENDOMETRIOSIS; GYNECOLOGIC DISEASE; HUMAN; NONHUMAN; OVARIECTOMY; OVARY CANCER; OVARY CARCINOMA; OVARY DISEASE; OVARY HYPERSTIMULATION; PARACENTESIS; REHYDRATION; REVIEW; TREATMENT RESPONSE; TUBERCULOUS PERITONITIS;

EID: 59149103156     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60003-6     Document Type: Review

References (100)

1. Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol 2007;18:945-9.
2. Mackey JR, Venner PM. Malignant ascites: demographics, therapeutic efficacy and predictors of survival. Can J Oncol 1996;6:474-80.
3. Parsons SL, Lang MW, Steele RJC. Malignant ascites: a 2-year review from a teaching hospital. Eur J Surg Oncol 1996;22:237-9.
4. Wilailak S, Linasmita V, Srivannaboon S. Malignant ascites in female patients: a seven-year review. J Med Assoc Thai 1999; 82:15-9.
5. Hirasawa T, Yasuda M, Muramatsu T, et al. Cytologic study of ascites and the endometrium in ovarian carcinoma. Clinical significance. Acta Cytol 1997;41:1451-5.
6. Kruitwagen RF, Swinkels BM, Keyser KG, Doesburg WH, Schijf CP. Incidence and effect on survival of abdominal wall metastases at trocar or puncture sites following laparoscopy or paracentesis in women with ovarian cancer. Gynecol Oncol 1996;60:233-7.
7. Nagarsheth NP, Rahaman J, Cohen CJ, Gretz H, Nezhat F. The incidence of port-site metastases in gynecologic cancers. JSLS 2004;8:133-9.
8. Aqua KA, Surwit EA, Childers JM. Abdominal-wall tumor implantation following laparoscopic for malignant conditions. J Am Assoc Gynecol Laparosc 1994;1:S1-2.
9. Childers JM, Aqua KA, Surwit EA, Hallum AV, Hatch KD. Abdominal-wall tumor implantation after laparoscopy for malignant conditions. Obstet Gynecol 1994;84:765-9.
10. Wang PH, Yen MS, Yuan CC, CHao KC, Ng HT, Lee WI, Chao HT. Port site metastasis after laparoscopic-assisted vaginal hysterectomy for endometrial cancer: possible mechanisms and prevention. Gynecol Oncol 1997;66:151-5.
11. Wang PH, Yuan CC, Lin G, Ng HT, Chao HT. Risk factors contributing to early occurrence of port site metastases of laparoscopic surgery for malignancy. Gynecol Oncol 1999; 72:38-44.
12. Schmeler KM, Sun CC, Bodurka DC, et al. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol 2008;108:510-4.
13. Morrison J, Swanton A, Collins S, Kehoe S. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev 2007;(4):CD005343.
14. Hou JY, Kelly MG, Yu H, McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol 2007; 105:211-7.
15. Brooks RA, Herzog TJ. Long-term semi-permanent catheter use for the palliation of malignant ascites. Gynecol Oncol 2006;101:360-2.
16. Gotlieb WH, Feldman B, Feldman-Moran O, et al. Intra-peritoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer. Gynecol Oncol 1998;71:381-5.
17. Easson A, Bezjak A, Ross S, Sam F, Newman A, Bana N, Wright JG. Changes in symptoms after paracentesis for symptomatic malignant ascites. J Clin Oncol 2005;23:6071.
18. Hamilton CA, Maxwell GL, Chernofsky MR, Bernstein SA, Farley JH, Rose GS. Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer. Gynecol Oncol 2008;doi:10.1016/ j.ygyno.2008.04.028.
19. Numnum TM, Rocconi RP, Whitworth J, Barnes MN. The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma. Gynecol Oncol 2006;102: 425-8.
20. Burges A, Wimberger P, Kümper C, et al. Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study. Clin Cancer Res 2007;13:3899-905.
21. Wang PH, Yuan CC. Tuberculous peritonitis. Am J Obstet Gynecol 2001;184:250-1.
22. Wang PH. Tuberculous peritonitis should be always considered as a differential diagnosis in abdominal carcinomatosis. Taiwan J Obstet Gynecol 2004;43:182-4.
23. Huang YJ, Wei LH, Hsieh CY. Clinical presentation of pelvic tuberculosis imitating ovarian malignancy. Taiwan J Obstet Gynecol 2004;43:29-34.
24. Sutherland AM. The changing pattern of tuberculosis of the female genital tract: a thirty-year survey. Arch Gynecol 1983; 234:95-101.
25. Sharma JB, Roy KK, Pushparaj M, Kumar S, Malhotra N, Mittal S. Laparoscopic findings in female genital tuberculosis. Arch Gynecol Obstet 2008;278:359-64.
26. Gürgan T, Zeyneloǧlu H, Urman B, Develioǧlu O, Yarali H. Pelvic-peritoneal tuberculosis with elevated serum and peritoneal fluid Ca-125 levels. A report of two cases. Gynecol Obstet Invest 1993;35:60-1.
27. Odejinmi F, Annan HG, Hussein SY. Tuberculosis, the great mimic again? A report of two cases of pelvic tuberculosis initially suspected to be advanced ovarian carcinoma. J Obstet Gynaecol 2000;20:544-5.
28. Sinha P, Johnson AN, Chidamberan-Pillai S. Pelvic tuberculosis: an uncommon gynaecological problem presenting as ovarian mass. BJOG 2000;107:139-40.
29. Bilgin T, Karabay A, Dolar E, Develioǧlu OH. Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases. Int J Gynecol Cancer 2001;11:290-4.
30. Koc S, Beydilli G, Tulunay G, et al. Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases. Gynecol Oncol 2006;103:565-9.
31. Chow TW, Lim BK, Vallipuram S. The masquerades of female pelvic tuberculosis: case reports and review of literature on clinical presentations and diagnosis. J Obstet Gynaecol Res 2002;28:203-10.
32. Ilhan AH, Durmusoglu F. Case report of a pelvic-peritoneal tuberculosis presenting as an adnexial mass and mimicking ovarian cancer, and a review of the literature. Infect Dis Obstet Gynecol 2004;12:87-9.
33. Mahdavi A, Malviya VK, Herschman BR. Peritoneal tuberculosis disguised as ovarian cancer: an emerging clinical challenge. Gynecol Oncol 2002;84:167-70.
34. Wang YC, Lu JJ, Chen CH, Peng YJ, Yu MH. Peritoneal tuberculosis mimicking ovarian cancer can be diagnosed by polymerase chain reaction: a case report. Gynecol Oncol 2005; 97:961-3.
35. Manidakis LG, Angelakis E, Sifakis S, Stefanaki P, Kalogeraki A, Manidaki A, Koumantakis E. Genital tuberculosis can present as disseminated ovarian carcinoma with ascites and raised Ca-125: a case report. Gynecol Obstet Invest 2001;51:277-9.
36. Piura B, Rabinovich A, Leron E, Yanai-Inbar I, Mazor M. Peritoneal tuberculosis mimicking ovarian carcinoma with ascites and elevated serum CA-125: case report and review of literature. Eur J Gynaecol Oncol 2002;23:120-2.
37. Wang PH, Yuan CC, Yu KJ, Chao HT. High resistance index of Doppler ultrasound in tuberculous peritonitis presenting as abdominal carcinomatosis. Chin Med J (Taipei) 1998; 61:175-9.
38. Uygur-Bayramicli O, Dabak G, Dabak R. A clinical dilemma: abdominal tuberculosis. World J Gastroenterol 2003;9:1098-101.
39. Ginesu F, Pirina P, Sechi LA, et al. Microbiological diagnosis of tuberculosis: a comparison of old and new methods. J Chemother 1998;10:295-300.
40. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 1993;88:989-99.
41. Donohoe RF, Shnider BI, Gorman J. Needle biopsy of the peritoneum; a preliminary report. AMA Arch Intern Med 1959;103:739-45.
42. Chow KM, Chow VC, Szeto CC. Indication for peritoneal biopsy in tuberculous peritonitis. Am J Surg 2003;185:567-73.
43. Mizunoe S, Morinaga R, Umeki K, et al. A case of tuberculous peritonitis diagnosed by ultrasonography-guided peritoneal biopsy. Kansenshogaku Zasshi 2000;74:589-93. [In Japanese]
44. Ylinen O. Genital tuberculosis in women: clinical experiences with 348 proved cases. Acta Obstet Gynecol Scand Suppl 1961; 40(Suppl 2):1-213.
45. Bhansali SK. Abdominal tuberculosis. Am J Gastroenterol 1977;67:324-7.
46. Wang PH, Yuan CC, Chao HT, Shu LP, Lai CR. Isolated tubal torsion managed laparoscopically. J Am Assoc Gynecol Laparosc 2000; 7:423-7.
47. Wang PH, Liu WM, Fuh JL, Chao HT, Yuan CC, Chao KC. Laparoscopic uterine vessel occlusion in the treatment of women with symptomatic uterine myomas with and without adding laparoscopic myomectomy - 4-year results. J Minim Invasive Gynecol 2008;15:712-8.
48. Wang PH, Lee WL, Yuan CC, Chin TW. Postpartum sterilization: the choice of laparoscopy or minilaparotomy? Eur J Obstet Gynecol Reprod Biol 2008;139:116-7.
49. Panoskaltsis TA, Moore DA, Haidopoulos DA, McIndoe AG. Tuberculous peritonitis: part of the differential diagnosis in ovarian cancer. Am J Obstet Gynecol 2000;182:740-2.
50. Inadomi JM, Kapur S, Kinkhabwala M, Cello JP. The laparoscopic evaluation of ascites. Gastrointest Endosc Clin N Am 2001; 11:79-91.
51. Sandikci MU, Colakoglu S, Ergun Y, Unal S, Akkiz H, Sandikci S, Zorludemir S. Presentation and role of peritoneoscopy in the diagnosis of tuberculous peritonitis. J Gastroenterol Hepatol 1992; 7:298-301.
52. Beerendonk CC, van Dop PA, Braat DD, Merkus JM. Ovarian hyperstimulation syndrome: facts and fallacies. Obstet Gynecol Surv 1998;53:439-49.
53. Budev MM, Arroliga AC, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med 2005;33(Suppl 10):S301-6.
54. Rizk B, Aboulghar MA. Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In: Brinsden P, ed. In Vitro Fertilization and Assisted Reproduction. New York: Parthenon Publishing Group, 1999:131-55.
55. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003;9:275-89.
56. Fluker MR, Copeland JE, Yuzpe AA. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome. Fertil Steril 2000;73:821-4.
57. Levin I, Almog B, Avni A, Baram A, Lessing JB, Gamzu R. Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Fertil Steril 2002;77:986-8.
58. Maslovitz S, Jaffa A, Eytan O, Wolman I, Many A, Lessing JB, Gamzu R. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstet Gynecol 2004; 104:321-6.
59. Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update 2003;9:77-96.
60. Chen CD, Wu MY, Yang JH, Chen SU, Ho HN, Yang YS. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. Fertil Steril 1997;68:287-91.
61. Chen SU, Chen CD, Yang YS. Ovarian hyperstimulation syndrome (OHSS): new strategies of prevention and treatment. J Formos Med Assoc 2008;107:509-12.
62. Alvarez C, Alonso-Muriel I, García G, Crespo J, Bellver J, Simón C, Pellicer A. Implantation is apparently unaffected by the dopamine agonist cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod 2007;22:3210-4.
63. Tsunoda T, Shibahara H, Hirano Y, et al. Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine. Gynecol Endocrinol 2003;17:281-6.
64. Alvarez C, Marti-Bonmati L, Novella-Maestre E, et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 2007;92:2931-7.
65. Meigs JV. Fibroma of the ovary with ascites and hydrothorax; Meigs' syndrome. Am J Obstet Gynecol 1954;67: 962-85.
66. Dockerty MB, Masson JC. Ovarian fibromas: a clinical and pathologic study of two hundred and eighty-three cases. Am J Obstet Gynecol 1944;47:741-52.
67. Sivanesaratnam V, Dutta R, Jayalakshmi P. Ovarian fibroma - clinical and histopathological characteristics. Int J Gynaecol Obstet 1990;33:243-7.
68. Meigs JV. Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol 1954;3:471-86.
69. Kazanov L, Ander DS, Enriquez E, Jaggi FM. Pseudo-Meigs' syndrome. Am J Emerg Med 1998;16:404-5.
70. Stratan D, Socolov R. Meigs' syndrome. A case report and review of literature. Rev Med Chir Soc Med Nat Lasi 1991; 96:30-2.
71. Terada S, Suzuki N, Uchide K, Akasofu K. Uterine leiomyoma associated with ascites and hydrothorax. Gynecol Obstet Invest 1992;33:54-8.
72. Amr SS, Hassan AA. Struma ovarii with pseudo-Meigs' syndrome: report of a case and review of the literature. Eur J Obstet Gynecol Reprod Biol 1994;55:205-8.
73. Schmitt R, Weichert W, Schneider W, Luft FC, Kettritz R. Pseudo-pseudo Meigs' syndrome. Lancet 2005;366:1672.
74. Ural UM, Kilic A, Gungor T, Ozdal B, Mollamahmutoglu L. Tjalma's or pseudo-pseudo-Meigs syndrome: a case report. Clin Exp Dermatol 2008;33:363-4.
75. Brews A. Endometriosis including endometriosis of the diaphragm and Meigs' syndrome. Proc R Soc Med 1951;47:461.
76. Spitzer M, Benjamin F. Ascites due to endometriosis. Obstet Gynecol Surv 1995;50:628-31.
77. Myers TJ, Arena B, Granai CO. Pelvic endometriosis mimicking advanced ovarian cancer: presentation with pleural effusion, ascites, and elevated serum CA 125 level. Am J Obstet Gynecol 1995;173:966-7.
78. Flanagan KL, Barnes NC. Pleural fluid accumulation due to intra-abdominal endometriosis: a case report and review of the literature. Thorax 1996;51:1062-3.
79. Muneyyirci-Delale O, Neil G, Serur E, Gordon D, Maiman M, Sedlis A. Endometriosis with massive ascites. Gynecol Oncol 1998;69:42-6.
80. Samora-Mata J, Feste JR. Endometriosis ascites: a case report. JSLS 1999;3:229-31.
81. Fletcher H, McFarlane M, Shirley SE, Clarke WF, Lyon K. Massive ascites secondary to severe endometriosis. West Indian Med J 1999; 48:158-9.
82. El Khalil T, Mourad FH, Barada K, Uthman S. Massive hemorrhagic ascites secondary to endometriosis. J Clin Gastroenterol 1999;29:344-5.
83. Crescini C, von Wunster S, Spazzini D. Ascites and pleural and pericardial effusion after operative laparoscopy. J Am Assoc Gynecol Laparosc 2000;7:155-7.
84. Bhojawala J, Heller DS, Cracchiolo B, Sama J. Endometriosis presenting as bloody pleural effusion and ascites - report of a case and review of the literature. Arch Gynecol Obstet 2000; 264:39-41.
85. Dias CC, Andrade JM, Ferriani RA, Villanova MG, Meirelles RS. Hemorrhagic ascites associated with endometriosis. A case report. J Reprod Med 2000;45:688-90.
86. Jeanes AC, Murray D, Davidson B, Hamilton M, Watkinson AF. Case report: hepatic and retro-peritoneal endometriosis presenting as obstructive jaundice with ascites: a case report and review of the literature. Clin Radiol 2002;57:226-9.
87. Francis M, Badero OO, Borowsky M, Lee YC, Abulafia O. Pericardial effusion, right-sided pleural effusion and ascites associated with stage IV endometriosis. A case report. J Reprod Med 2003;48:463-5.
88. Cheong EC, Lim DT. Massive ascites - an uncommon presentation of endometriosis. Singapore Med J 2003;44:98-100.
89. Donnez J, Jadoul P. Ascites and pelvic masses: an unusual case of endometriosis. Fertil Steril 2005;83:195-7.
90. Goumenou A, Matalliotakis I, Mahutte N, Koumantakis E. Endometriosis mimicking advanced ovarian cancer. Fertil Steril 2006; 86:219.e23-5.
91. Palayekar M, Jenci J, Carlson JA Jr. Recurrent hemorrhagic ascites: a rare presentation of endometriosis. Obstet Gynecol 2007;110:521-2.
92. Zeppa P, Vetrani A, Cozzolino I, Palombini L. Endometrial glands in ascites secondary to endometriosis. Diagn Cytopathol 2004; 30:131-2.
93. Lin JN, Lin HL, Huang CK, Lai CH, Chung HC, Liang SH, Lin HH. Endometriosis presenting as bloody ascites and shock. J Emerg Med 2008;doi:10.1016/j.jemermed.2008.03.031.
94. Bernstein JS, Perlow V, Brenner JJ. Massive ascites due to endometriosis. Am J Dig Dis 1961;6:1-6.
95. Wang PH, Liu WM, Fuh JL, Cheng MH, Chao HT. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril 2008;doi:10.1016/ j.fertnstert.2008.07.1744.
96. Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/ intracytoplasmic sperm injection cycles. Fertil Steril 2007;88:832-9.
97. Fedele L, Bianchi S, Montefusco S, Frontino G, Carmignani L. A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis. Fertil Steril 2008;90:183-4.
98. Ghosh SB, Mala YM, Tripathi R, Tyagi S. Coexisting genital tuberculosis and endometriosis presenting as abdominal mass in an infertile woman: a report of a rare case. Fertil Steril 2008;90:443.e5-6.
99. Lebovic DI, Mwenda JM, Chai DC, Mueller MD, Santi A, Fisseha S, D'Hooghe T. PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study. Fertil Steril 2007;88:1108-19.
100. Saito S, Murakami T, Suzuki K, Terada Y, Fukushima K, Moriya T. Intestinal endometriosis complicated by ileal perforation after initiation of gonadotropin-releasing hormone agonist therapy. Fertil Steril 2007;88:969.e7-9.